Rapid test development for infectious disease states is one of the fasted growing areas of diagnostic assay development. BiosPacific is always looking for new and innovative products to bring to the market. We have expanded our portfolio to include more infectious disease markers such as Borrelia burgdorferi (Lyme), Chlamydia, CMV, Corona Virus, Dengue, HIV, Influenza A and B, Malaria HRP II, Strep A and even ZIKA.
We also have excellent secondary antibodies for use in infectious disease serology assays. We offer IgG, IgA and IgM monoclonal antibodies as well as affinity pure polyclonals specific to different regions of the immunoglobulin proteins like Fc and H+L.
BiosPacific can supply various antibodies and antigens for each of the disease states and we continue to develop and grow our catalog as the market grows. Please contact us to inquire about any other antibodies or proteins you may require.
latest additions to our portfolio
• Influenza A Monoclonals
• Dengue NS1 Monoclonals and Antigens
• SARS-CoV-2 (COVID-19) Monoclonals and Antigens